Biodesix (BDSX) Stock Price Target 2026

The average analyst price target for Biodesix is $37.63, 275.5% above the current price. Of 7 analysts, 7 rate it Buy. Targets range from $30 to $60. The latest change came on Nov 9, 2026, when HC Wainwright & Co. lowered its price target on Biodesix from $38 to $34 and kept a Buy rating.

The Average Analyst Price Target for Biodesix is $37.63.

Price Target Range — 10 Quarters

Analyst Consensus — 7 Analysts

7Buy

Consensus RatingBuy# Analysts7Avg. Consensus PT$37.63Upside to Avg. PT+275.5%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Biodesix Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 9, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$38→$34
Nov 6, 2026	Lake Street	Thomas Flaten	PT Cut	Buy	$40→$30
Oct 13, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$30→$40
Sep 25, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$27→$38
Aug 10, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$27→$35
Aug 6, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$26→$27
Jun 25, 2026	Roth Capital	Max Masucci	Initiate	Buy	$32
Jun 18, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$22→$27
Jun 15, 2026	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$26
May 5, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$20→$22
Feb 27, 2026	William Blair	Brian Weinstein	Upgrade	Market Perform→Outperform	—
Feb 17, 2026	Canaccord Genuity	Kyle Mikson	Maintained	Buy	$20
Sep 19, 2025	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$30→$20
May 21, 2025	Scotiabank	Sung Ji Nam	PT Cut	Sector Outperform	$60→$40
May 14, 2025	Craig-Hallum	Bill Bonello	PT Cut	Buy	$60→$30
May 14, 2025	Lake Street	Thomas Flaten	PT Cut	Buy	$60→$40
May 14, 2025	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$50→$30
May 14, 2025	William Blair	Brian Weinstein	Downgrade	Outperform→Market Perform	—
Apr 29, 2025	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$70→$50
Sep 16, 2024	Scotiabank	Sung Ji Nam	Initiate	Sector Outperform	$60